Johnson & Johnson (JNJ) has recalled more than 157K surgical stapler devices and accessories used in hemorrhoid treatment procedures due to potential malfunctions that pose a serious safety risk. The FDA says use of the recalled devices could cause serious adverse health consequences, including death. The agency assigned its most serious classification, Class 1, to the recall last week.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs